Item does not contain fulltextThe Dutch Medicines Act and the Medical Treatment Contracts Act (WGBO) form the legal framework for off-label prescribing. These acts are complemented with position statements and guidelines of professional organizations. However, this legal framework is not yet sufficiently embedded in daily practice. The explicit translation of the legal conditions into practical stepwise guidance can therefore provide important guidance when prescribing off-label. This article describes a step-by-step guide for responsible off-label prescribing. The step-by-step guide ensures that decisions about off-label use of drugs are made based on a deliberate and explicit consideration of the unmet medical need and alternative treatme...
World experience in off-label medicines use is presented in the article. Data on the history of chan...
Prescribing a medication for a condition not described in the label approved by national regulatory ...
Purpose The aim of this study is to quantify the extent of ill-founded off-label drug prescriptions ...
• Off-label prescribing is the prescription of a registered medicine for a use that is not included ...
Off-label geneesmiddelen voorschrijven blijkt een vanzelfsprekend onderdeel te zijn van de medische ...
La prescription de médicament hors AMM est légitime quand elle s’appuie sur les connaissances médica...
Aim: Off-label prescription is not regulated on the European Union (EU) level and therefore not harm...
This book examines the regulatory framework for untested and unapproved uses (off-label uses) of med...
Contains fulltext : 71297.pdf (publisher's version ) (Closed access)Off-label medi...
Off label prescription occurs when a drug is prescribed for an indication, a route of administratio...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
INTRODUCTION Concern about off-label prescriptions, that is to say prescriptions of a drug for thera...
Background: Medicine use is considered off-label when used for an indication, at a dose, via a route...
Approval of a drug for clinical use requires production of data on efficacy and safety through submi...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...
World experience in off-label medicines use is presented in the article. Data on the history of chan...
Prescribing a medication for a condition not described in the label approved by national regulatory ...
Purpose The aim of this study is to quantify the extent of ill-founded off-label drug prescriptions ...
• Off-label prescribing is the prescription of a registered medicine for a use that is not included ...
Off-label geneesmiddelen voorschrijven blijkt een vanzelfsprekend onderdeel te zijn van de medische ...
La prescription de médicament hors AMM est légitime quand elle s’appuie sur les connaissances médica...
Aim: Off-label prescription is not regulated on the European Union (EU) level and therefore not harm...
This book examines the regulatory framework for untested and unapproved uses (off-label uses) of med...
Contains fulltext : 71297.pdf (publisher's version ) (Closed access)Off-label medi...
Off label prescription occurs when a drug is prescribed for an indication, a route of administratio...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
INTRODUCTION Concern about off-label prescriptions, that is to say prescriptions of a drug for thera...
Background: Medicine use is considered off-label when used for an indication, at a dose, via a route...
Approval of a drug for clinical use requires production of data on efficacy and safety through submi...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...
World experience in off-label medicines use is presented in the article. Data on the history of chan...
Prescribing a medication for a condition not described in the label approved by national regulatory ...
Purpose The aim of this study is to quantify the extent of ill-founded off-label drug prescriptions ...